NCR1 and laryngotracheoesophageal cleft: First, activation receptor (NKp30-, NKp44-, NKp46- and NKG2D)-expressing NK cells were reduced, whereas inhibitory receptor (CD158a/b)-expressing NK cells were increased in the livers of HBV-LC patients compared with CHB subjects.